Exploring the Potential of Large Language Models in Personalized Diabetes Treatment Strategies

Author:

Yang Hao1,li jiaxi2,liu siru3,Liu Jialin1

Affiliation:

1. West China Hospital of Sichuan University

2. Jinniu Maternity and Child Health Hospital of Chengdu

3. Vanderbilt University Medical Center

Abstract

Abstract Object: This study aims to explore the application of a fine-tuned model-based outpatient treatment support system for the treatment of patients with diabetes and evaluate its effectiveness and potential value. Methods: The ChatGLM model was selected as the subject of investigation and trained using the P-tuning and LoRA fine-tuning methods. Subsequently, the fine-tuned model was successfully integrated into the Hospital Information System (HIS). The system generates personalized treatment recommendations, laboratory test suggestions, and medication prompts based on patients' basic information, chief complaints, medical history, and diagnosis data. Results: Experimental testing revealed that the fine-tuned ChatGLM model is capable of generating accurate treatment recommendations based on patient information, while providing appropriate laboratory test suggestions and medication prompts. However, for patients with complex medical records, the model's outputs may carry certain risks and cannot fully substitute outpatient physicians' clinical judgment and decision-making abilities. The model's input data is confined to electronic health record (EHR), limiting the ability to comprehensively reconstruct the patient's treatment process and occasionally leading to misjudgments of the patient's treatment goals. Conclusion: This study demonstrates the potential of the fine-tuned ChatGLM model in assisting the treatment of patients with diabetes, providing reference recommendations to healthcare professionals to enhance work efficiency and quality. However, further improvements and optimizations are still required, particularly regarding medication therapy and the model's adaptability.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs;Artasensi A;Molecules,2020

2. WHO|Diabetes Programme. WHO. [(accessed on 27 January 2019)];2019 Available online: https://www.who.int/diabetes/en/.

3. Therapy of Type 2 Diabetes;Landgraf R;Exp Clin Endocrinol Diabetes,2019

4. A Markov decision process for modeling adverse drug reactions in medication treatment of type 2 diabetes;Eghbali-Zarch M;Proc Inst Mech Eng H,2019

5. Gpts are gpts: An early look at the labor market impact potential of large language models[J];Eloundou T,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3